Literature DB >> 16757289

Acute renal failure requiring renal replacement therapy after orthotopic liver transplantation.

S Faenza1, A Santoro, E Mancini, S Pareschi, A Siniscalchi, C Zanzani, A D Pinna.   

Abstract

OBJECTIVES: Acute renal failure (ARF) is a severe complication in patients undergoing orthotopic liver transplantation (OLT), which predicts a poor outcome. The aim of this study was to analyze risk factors for the development of ARF, including severity of illness, onset time of ARF prognostic factors of outcome, and mortality in a group of critically patients requiring renal replacement therapy (RRT).
METHODS: Retrospective analysis of 240 consecutive liver transplant cases from 1999 to 2001 admitted to the intensive care unit (ICU) was performed to identify risk factors for ARF development after OLT. The analyzed factors were: age, sex, CrS, BUN, diuresis, sepsis, hypovolemia, cardiac failure, nephrotoxic drugs (cyclosporine or FK506, antibiotics), hyperbilirubinemia, associated diseases (DM, CRF), onset time of renal failure and progressiveness, timing of RRT, number of days of RRT, and mortality. We examined variables upon admission to the ICU, before the first RRT, and on the last ICU day before resignation or death. We used Students' t test. Quantitative parameters were expressed as mean values +/- SD.
RESULTS: Of the 240 patients, 20 (8.3%) experienced ARF needing renal replacement therapy during the postoperative period. The results of our study suggested that ARF among patients undergoing RRT conferred an excessive risk of in-hospital death: eight patients died (40%). This increased risk cannot be explained solely by a more pronounced severity of illness.
CONCLUSION: Our results provide strong evidence that ARF presents a specific, independent risk factor for a poor prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 16757289     DOI: 10.1016/j.transproceed.2006.02.151

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  9 in total

1.  Incidence and risk factors for early renal dysfunction after liver transplantation.

Authors:  Patricia Wiesen; Paul B Massion; Jean Joris; Olivier Detry; Pierre Damas
Journal:  World J Transplant       Date:  2016-03-24

2.  Dual Effects of Bilirubin on the Proliferation of Rat Renal NRK52E Cells and ITS Association with Gap Junctions.

Authors:  Yanling Wang; Qiongfang Zhu; Chenfang Luo; Ailan Zhang; Ziqing Hei; Guangjie Su; Zhengyuan Xia; Michael G Irwin
Journal:  Dose Response       Date:  2012-07-30       Impact factor: 2.658

3.  Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients.

Authors:  Christian E Oberkofler; Philipp Dutkowski; Reto Stocker; Reto A Schuepbach; John F Stover; Pierre-Alain Clavien; Markus Béchir
Journal:  Crit Care       Date:  2010-06-15       Impact factor: 9.097

4.  Epidemiology and clinical features of post-transplant bloodstream infection: an analysis of 222 consecutive liver transplant recipients.

Authors:  Hyun Kyung Kim; Yong Keun Park; Hee-Jung Wang; Bong Wan Kim; So Youn Shin; Seung-Kwan Lim; Young Hwa Choi
Journal:  Infect Chemother       Date:  2013-09-27

5.  Critical care issues in adult liver transplantation.

Authors:  Palepu B Gopal; Dharmesh Kapoor; Ravichandra Raya; M Subrahmanyam; Deven Juneja; B Sukanya
Journal:  Indian J Crit Care Med       Date:  2009 Jul-Sep

6.  The relationship between preoperative creatinine clearance and outcomes for patients undergoing liver transplantation: a retrospective observational study.

Authors:  Urs Wenger; Thomas A Neff; Christian E Oberkofler; Manuel Zimmermann; Paul A Stehberger; Marcel Scherrer; Reto A Schuepbach; Silvia R Cottini; Peter Steiger; Markus Béchir
Journal:  BMC Nephrol       Date:  2013-02-14       Impact factor: 2.388

7.  Impact of acute kidney injury exposure period among liver transplantation patients.

Authors:  Roberto Camargo Narciso; Leonardo Rolim Ferraz; Sergio Mies; Julio Cesar Martins Monte; Oscar Fernando Pavão dos Santos; Miguel Cendoroglo Neto; Cassio José de Oliveira Rodrigues; Marcelo Costa Batista; Marcelino Souza Durão
Journal:  BMC Nephrol       Date:  2013-02-20       Impact factor: 2.388

Review 8.  Critical Care of the Liver Transplant Recipient.

Authors:  Thomas M A Fernandez; Paul J Gardiner
Journal:  Curr Anesthesiol Rep       Date:  2015-12-01

9.  High output cardiac failure in 3 patients with hereditary hemorrhagic telangiectasia and hepatic vascular malformations, evaluation of treatment.

Authors:  Lilian B Olsen; Anette D Kjeldsen; Mikael K Poulsen; Jens Kjeldsen; Annette D Fialla
Journal:  Orphanet J Rare Dis       Date:  2020-11-26       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.